Other · developed by Pacira Pharmaceuticals
FX005 is a drug given by intra-articular injection into the knee.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT01291914 | Phase 1/2 | Osteoarthritis, Knee | Completed | PCRX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Osteoarthritis, Knee
Updated Oct 25, 2026. Something wrong or missing? Report it on the PCRX page.
See PCRX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PCRX catalysts and pipeline →